# Ischemic Central Retinal Vein Occlusion Accompanied by Macular Edema: A Case Report

**Authors:** Yuga Pawar, Sachin Daigavane, Archana R Thool, Uma Swaminathan, Zoya Javed

PMC · DOI: 10.7759/cureus.66152 · 2024-08-05

## TL;DR

A 39-year-old man with diabetes developed a rare eye condition causing vision loss, linked to insulin resistance and treated with injections.

## Contribution

The paper presents a rare case of ischemic central retinal vein occlusion with macular edema caused by insulin resistance.

## Key findings

- A 39-year-old male developed ischemic central retinal vein occlusion with macular edema.
- The primary risk factor identified was insulin resistance.
- Close monitoring and diabetes management are recommended to prevent such complications.

## Abstract

One of the primary reasons for discernible or complete loss of sight in middle-aged and older persons is central retinal vein occlusion (CRVO). Three intravitreal bevacizumab (Avastin) injections were administered to a 39-year-old male patient as part of his therapy for his prior diabetic retinopathy due to uncontrolled diabetes. The patient was advised to undergo gonioscopy and an undilated iris examination to look for angle neovascularization during the next three months of follow-up. We demonstrated an extraordinary instance of unilateral ischemia CRVO (macular edema), where the main cause of risk was insulin resistance. To avoid a situation like this, close observation and diabetes management are recommended.

## Linked entities

- **Diseases:** diabetes (MONDO:0005015), central retinal vein occlusion (MONDO:0002303), macular edema (MONDO:0003005)

## Full-text entities

- **Diseases:** Macular Edema (MESH:D008269), CRVO (MESH:D012170), unilateral ischemia (MESH:D007511), insulin resistance (MESH:D007333), diabetic retinopathy (MESH:D003930), loss of sight (MESH:D016388), diabetes (MESH:D003920)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11372339/full.md

---
Source: https://tomesphere.com/paper/PMC11372339